Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
NCT Number: NCT06745154
This clinical trial evaluates the impact of Quitting Using Executive Function Strategy Training (QUEST) on quitting smoking (cessation) in homeless young adult smokers with an acquired brain injury (ABI). Over 70% of youth and young adults experiencing homelessness (YYEH) smoke tobacco. More than half of YYEH who smoke have made at least one attempt to quit smoking but few use evidence-based methods to increase success. In addition, 9 out of 10 of these have an acquired brain injury which may have a negative impact on successful smoking cessation. QUEST may help homeless young adult smokers with an ABI quit smoking.
Looking for future studies?
Notify Me18 year–24 year
All sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
PRIMARY OBJECTIVES:
I. Gather data needed to build QUEST (Quitting Using Executive function Strategy Training), an intervention to help youth and young adults (YYEH) with executive function dysregulation better 1) access evidence-based cessation; 2) adhere to processes of evidence-based treatment; and 3) address stress to prevent relapse.
II. Establish the feasibility of collecting acquired brain injury (ABI) status, and impact data sensitive to change over time (clinical and epigenetic), from YYEH tobacco users in community settings.
EXPLORATORY OBJECTIVE:
I. Determine if 1) executive functioning 2) mild cognitive impairment and 3) epigenetic age & other biomarkers of health risk measures are sensitive to difference by ABI status among YYEH past week combustible tobacco users.
OUTLINE:
Patients receive access to the Ohio Tobacco Quitline, receive nicotine patches, gum, or lozenges for up to 8 weeks. Patients also participate in tobacco cessation counseling sessions for 5 sessions over 8 weeks. Patients additionally undergo cognitive assessment and nasal swab collection on study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Undergo nasal swab collection
Other names: Biological Sample Collection, Biospecimen Collected, Specimen Collection
Undergo cognitive assessment
Ancillary studies
Given nicotine patches, gum, or lozenges
Other names: Nicotine Replacement Therapy, NRT
Receive access to the Ohio Tobacco Quit Line
Other names: Smoking and Tobacco Use Cessation Interventions
Ancillary studies
Participate in counseling sessions
Time frame: Up to 8 weeks
The number of times participants experience executive function difficulties with adhering to the Quit Line protocol will be recorded via survey questionnaires.
Time frame: Up to 8 weeks
All factors reported by participants via survey questionnaires that impacted their ability to access Quit Line treatment will be recorded.
Time frame: Up to 8 weeks
The number of contacts each participant had with the Quit Line throughout the study will be recorded via survey questionnaires.
Time frame: Up to 8 weeks
The number of times participants made use of nicotine replacement therapies throughout the length of the study will be recorded via survey questionnaires.
Ohio State University Comprehensive Cancer Center
Other
QUEST (Quitting Using Executive Function Strategy Training) Research Protocol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06038526
Cigarette Smoking-Related Carcinoma, Lung Carcinoma
Columbus, Ohio, United States
View Trial DetailsNCT05825001
Cigarette Smoking-Related Carcinoma
Buffalo, New York, United States
View Trial DetailsNCT06230159
Cigarette Smoking-Related Carcinoma
Columbus, Ohio, United States
View Trial DetailsNCT03856515
Cigarette Smoking-Related Carcinoma
Houston, Texas, United States
View Trial Details